No Data
No Data
Liuzhou Liangmianzhen's (SHSE:600249) Earnings Are Weaker Than They Seem
Announcement of the main operating data of Double Sided Needle for the third quarter of 2024
Double-Sided Needle 2024 Third Quarter Report
liuzhou liangmianzhen (600249.SH): The net income in the first three quarters was 84.0174 million yuan, a year-on-year increase of 316.51%.
Geelonghui, October 29th | Liuzhou Liangmianzhen (600249.SH) announced the third quarter report of 2024, with the company's revenue for the first three quarters of 0.791 billion yuan, a year-on-year increase of 17.26%; net income attributable to shareholders of the listed company was 84.0174 million yuan, a year-on-year increase of 316.51%; and the basic earnings per share were 0.1528 yuan.
LiuZhou Liangmianzhen (600249.SH) released its performance for the first three quarters, with a net income of 84.0174 million yuan, a year-on-year increase of 316.51%.
liuzhou liangmianzhen (600249.SH) released the third quarter report for 2024, with revenue for the first three quarters of the company at 7.9...
liuzhou liangmianzhen (600249.SH): Intends to participate in the establishment of an industrial fund with 0.15 billion yuan.
GeLongHui October 11th | Liuzhou Liangmianzhen (600249.SH) announced that the company plans to jointly establish the Liuzhou Liangmianzhen Health Industry Investment Partnership Enterprise (Limited Partnership) with Minsheng Private Equity Fund Management Co., Ltd., Guangxi Investment Guidance Fund Co., Ltd., and Liuzhou Industrial Guidance Fund Investment Management Co., Ltd. (tentative name, subject to the final registration name approved by the enterprise registration authority). The source of funds for this investment is the company's own funds. The fund size is RMB 0.5 billion, with the company contributing RMB 150 million as a limited partner, accounting for 30% of the total fund size. The partnership enterprise mainly
No Data
No Data